Aim Retinal oxygen metabolism is thought to be affected in diabetic retinopathy. The aim of this study was to test whether retinal vessel oxygen saturation is different in patients with diabetic retinopathy from that in healthy controls.
Methods The retinal oximeter is based on a fundus camera. It estimates retinal vessel oxygen saturation from light absorbance at 586 nm and 605 nm. Retinal vessel oxygen saturation was measured in one major temporal retinal arteriole and venule in healthy volunteers and in patients with diabetic retinopathy.
Results Oxygen saturation in the retinal arterioles of healthy volunteers was 93±4% and 58±6% in venules (mean±SD, n=31). The corresponding values for all diabetic patients (n=20) were 101±5% and 68±7%. The difference between healthy volunteers and diabetic patients was statistically significant (p<0.001 for arterioles and venules). Three subgroups of diabetic patients (background retinopathy, macular oedema and pre-proliferative/proliferative retinopathy) all had higher saturation values than the healthy volunteers (p<0.05 for arterioles and venules).
Conclusion Retinal vessel oxygen saturation is higher in patients with diabetic retinopathy than in healthy controls. Possible explanations include shunting of blood through preferential channels, bypassing non-perfused capillaries in the capillary network. Parts of the retinal tissue may be hypoxic while blood in larger vessels has high oxygen saturation.
- diabetic retinopathy
- image processing
- retinal vessels
- public health
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding Icelandic Centre for Research (Rannís), Eimskip University Fund, Univ. of Iceland Research Fund and Landspítali-University Hospital Research Fund.
Competing interests Both authors are involved in the development of the instrument (oximeter) used and have a financial interest in the company Oxymap ehf., which makes this instrument. The first author is an employee of the University of Iceland but Oxymap ehf. partly supports the position.
Patient consent Obtained.
Ethics approval Ethics approval was provided by National Bioethics Committee of Iceland and the Icelandic Data Protection Authority.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement Additional data are available upon request from the corresponding author: Einar Stefánsson, ( ).